[photo credit: Doheny Eye Institute]
SriniVas Sadda, MD, directs artificial intelligence and imaging research at the Doheny Eye Institute, headquartered at 150 N. Orange Grove Blvd. He is also a professor of ophthalmology at the UCLA David Geffen School of Medicine. His research focuses on retinal image analysis and developing AI tools to detect signs of the disease, according to his institutional biography, and is funded by multiple grants from the National Institutes of Health, including two from the National Eye Institute.
The condition he studies is common. An estimated 20 million Americans aged 40 and older have some form of AMD, according to a 2022 study published in JAMA Ophthalmology using data from the Centers for Disease Control and Prevention. Approximately one in 10 Americans over 50 has the disease. Among those 80 and older, roughly three in 10 do. AMD damages the macula, the part of the retina responsible for sharp central vision, and has no cure in its advanced stages.
The April 20 session, titled “Ask the Doctor: A Conversation with Dr. SriniVas Sadda,” runs from 1 to 2:30 p.m. in the second-floor conference center at Doheny’s Pasadena headquarters. Dr. Sadda will discuss the latest advances in AMD diagnosis and treatment, including the role of AI, and offer practical guidance on how to talk with a doctor about the condition, according to the event page.
Two additional researchers will present. Yali Jia, a professor of ophthalmology and biomedical engineering at Oregon Health & Science University, will discuss OCT angiography in systemic diseases. Jianhua Wang, a professor at the Bascom Palmer Eye Institute at the University of Miami, will present on retinal biomarkers. Giulia Corradetti, a scientist at Doheny Eye Institute, will moderate, according to the event page.
Dr. Sadda’s credentials extend well beyond Pasadena. He received his medical degree from Johns Hopkins University and completed his ophthalmology residency and fellowships in neuro-ophthalmology and medical retina at the Wilmer Eye Institute, according to his Doheny biography. He has authored more than 725 peer-reviewed publications and 20 book chapters, delivered more than 500 presentations worldwide, and serves as editor-in-chief of the seventh edition of Ryan’s Retina, the biography states. He served as president of the Association for Research in Vision and Ophthalmology for the 2024-2025 term, was named president of the Macula Society, and has been recognized on the Best Doctors of America list for several consecutive years, according to a Doheny press release.
Deborah A. Ferrington, chief scientific officer at Doheny Eye Institute, said in a press release announcing Dr. Sadda’s appointment to the A. Ray Irvine Jr., MD, Endowed Chair in Clinical Ophthalmology that he “has made a remarkable impact on the field of ophthalmology and in vision research, and has a stellar reputation around the globe for his leadership and expertise.”
Doheny Eye Institute is a nonprofit vision research organization founded in 1947. It has been headquartered on the seven-acre North Orange Grove Boulevard campus — formerly the Avery Dennison headquarters — since 2022. Affiliated with the UCLA Stein Eye Institute since 2013, the combined program is ranked among the top five vision centers in the country by U.S. News & World Report, according to a Doheny press release.
The event is free. For more information, call (323) 342-7101 or visit doheny.org.
“New technologies, artificial intelligence, and continued collaboration among scientists globally continues to push forward knowledge,” Dr. Sadda said in the Doheny press release, “and I am eager to continue my part in the crucial effort to help save people’s sight.”
ASK THE DOCTOR: A CONVERSATION WITH DR. SRINIVAS SADDA Date & Time: Monday, April 20, 2026, 1:00 p.m. | Venue: Doheny Eye Institute 2nd Floor Conference Center, 150 N. Orange Grove Blvd., Pasadena, CA 91108 | Website: https://doheny.org/event/ask-the-doctor-a-conversation-with-dr-srinivas-sadda/
